Technology area: Chemistry & Materials
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Cypher Medical LLC maintains a company patent portfolio within the Chemistry & Materials technology area. The data indicates a total of 3 pending office actions. These actions are concentrated under 1 distinct examiner and 1 distinct art unit, which represents a narrow point of contact for the entire portfolio.
GERIDO, DWAN A serves as the busiest examiner for this entity. This individual is currently managing 3 busiest examiner pending office actions. This count matches the total of 3 pending office actions for the company, meaning one person oversees all active matters.
The focus on 1 distinct art unit suggests a specialized application of Chemistry & Materials. For legal strategy, the reliance on 1 distinct examiner implies that outcomes for all 3 pending office actions are likely to be influenced by a singular examiner's interpretation of the prior art.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GERIDO, DWAN A | 2 | 58.1% | +30.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17877765 | METHOD AND SYSTEM FOR APPROXIMATING BLOOD VOLUME IN A FLUID | GERIDO, DWAN A | — |
| 17871754 | METHOD OF ESTIMATING BLOOD VOLUME | GERIDO, DWAN A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17877765 | METHOD AND SYSTEM FOR APPROXIMATING BLOOD VOLUME IN A FLUID | GERIDO, DWAN A | — |
| 17871754 | METHOD OF ESTIMATING BLOOD VOLUME | GERIDO, DWAN A | — |
| Art Unit | Apps |
|---|---|
| 1797 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17877765 | METHOD AND SYSTEM FOR APPROXIMATING BLOOD VOLUME IN A FLUID | GERIDO, DWAN A | 1797 | §101 | Non-Final OA | — | Pending | Jul 29, 2022 |
| 17871754 | METHOD OF ESTIMATING BLOOD VOLUME | GERIDO, DWAN A | 1797 | §101 | Non-Final OA | — | Pending | Jul 22, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCypher Medical LLC has 2 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Dwan A Gerido has the most, with 2 of Cypher Medical LLC's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
